Yang Y, Liu Y, Sun H, Meng L, Lin H, Chen C, Hu J, Shen X, Duan M, Zhang Y, Abulaiti D, Wang J, Zhu H, Hua L, Leng Q, Zhang C, Sun L, Li W, Zhu H, Liu B, Wang J. Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia. haematol [Internet]. 2020Sep.10 [cited 2024Jul.8];. Available from: https://haematologica.org/article/view/haematol.2023.284892